Advertisement
Advertisement
August 9, 2015
Jotec Launches Enhanced E-vita Thoracic 3G System in Europe
August 10, 2015—Jotec GmbH announced that the company’s updated E-vita thoracic 3G stent graft system recently received European CE Mark approval for the treatment of lesions of the thoracic aorta. The device is now available in markets that recognize CE Mark certification.
The new delivery system catheter incorporates the company’s Triple-P (Patented Pearl Pusher) technology, which uses individually wound pearls that act as pushers during deployment of the stent graft. The alignment of the pearls along the catheter provides enhanced flexibility and trackability of the catheter during use.
According to the company, the Triple-P technology allows for crossing of the most tortuous and angulated vessel anatomies, and the stent graft can be placed precisely and safely. The Triple-P technology is embedded in the device’s squeeze-to-release mechanism and the ergonomically designed delivery system. The E-vita thoracic 3G delivery system has a low crossing profile, starting at 20 F. Furthermore, the device’s hydrophilic coating facilitates introduction and advancement into the vessels, stated Jotec.
Advertisement
Advertisement
